Nephrocare Health IPO Subscription Status

Detailed category-wise subscription breakdown with historical data

About Nephrocare Health IPO Subscription

Track the Nephrocare Health IPO subscription status with comprehensive data across all investor categories. The IPO subscription window was open from Dec 10, 2025 to Dec 12, 2025. Subscription data is categorized into Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII), and Retail Individual Investors (Retail).

The NII category is further divided into bNII (bids above ₹10 lakh) and sNII (bids below ₹10 lakh) to provide granular insights into subscription patterns. The overall subscription for Nephrocare Health IPO stands at 9.15 times.

Subscription rates indicate the level of investor interest - a higher subscription multiple suggests strong demand, while lower multiples may indicate moderate interest. This data helps investors understand market sentiment and make informed decisions about the IPO.

Latest Subscription Snapshot

As of December 17, 2025

Total Subscription
9.15×
Investor Category Shares Offered Shares Bid For Subscribed (Times)
QIB
Qualified Institutional Buyers
 3,678,793 58,882,208 16.01×
NII
Non-Institutional Investors
 2,886,270 51,571,328 17.87×
bNII
Bids above ₹10L
 1,924,180 42,350,688 22.01×
sNII
Bids below ₹10L
 962,090 9,220,640 9.58×
Retail Investors
Retail Individual Investors
 6,734,630 11,292,544 1.68×
Total
 13,299,693 121,746,080 9.15×

Subscription History

Historical subscription data grouped by date

Dec 17, 2025

Wednesday

Category Shares Offered Shares Bid For Times
QIB 3,678,793 58,882,208 16.01×
NII 2,886,270 51,571,328 17.87×
bNII 1,924,180 42,350,688 22.01×
sNII 962,090 9,220,640 9.58×
Retail 6,734,630 11,292,544 1.68×
Total 13,299,693 121,746,080 9.15×

Frequently Asked Questions about Nephrocare Health IPO IPO Subscription

Common questions and answers about Nephrocare Health IPO subscription status, dates, and allotment

What is the current subscription status of Nephrocare Health IPO IPO?

As of December 17, 2025, the Nephrocare Health IPO IPO has been subscribed 9.15 times overall. The IPO is fully subscribed.

When was the Nephrocare Health IPO IPO subscription window open?

The Nephrocare Health IPO IPO subscription window was open from December 10, 2025 to December 12, 2025. Investors could apply for shares during this period through their demat account or ASBA facility.

What is the price band and minimum investment for Nephrocare Health IPO IPO?

The Nephrocare Health IPO IPO has a price band of ₹438 to ₹460 per share. The lot size is 32 shares, which means retail investors need to apply for a minimum of 32 shares. The minimum investment required is ₹14,016 (at lower price) or ₹14,720 (at upper price).

What is the QIB subscription for Nephrocare Health IPO IPO?

The Qualified Institutional Buyers (QIB) category for Nephrocare Health IPO IPO has been subscribed 16.01 times. QIBs were offered 3,678,793 shares in this IPO. QIB category includes foreign institutional investors (FIIs), domestic mutual funds, banks, insurance companies, and other qualified institutional investors. The strong QIB subscription indicates high institutional investor confidence in Nephrocare Health IPO.

What is the Retail subscription for Nephrocare Health IPO IPO?

The Retail Individual Investors (RII) category for Nephrocare Health IPO IPO has been subscribed 1.68 times. Retail investors were offered 6,734,630 shares in this IPO. Retail category includes individual investors applying for shares up to ₹2 lakh.

What is the NII subscription for Nephrocare Health IPO IPO?

The overall Non-Institutional Investors (NII) category has been subscribed 17.87 times. The NII category is further divided into bNII (bids above ₹10 lakh) with 22.01 times subscription and sNII (bids below ₹10 lakh) with 9.58 times subscription. NII category includes high net-worth individuals (HNIs) and corporate entities investing above ₹2 lakh. The subscription data helps analyze the interest level from high-value investors in Nephrocare Health IPO IPO.

How can I check my Nephrocare Health IPO IPO allotment status?

The basis of allotment date for Nephrocare Health IPO IPO will be announced soon. You can check your allotment status by visiting the registrar's website (Kfin Technologies Ltd) and entering your PAN number, application number, or DP ID. Alternatively, you can check through your demat account or the stock exchange website (NSE/BSE).

When will Nephrocare Health IPO IPO be listed and on which exchange?

The listing date for Nephrocare Health IPO IPO will be announced after the basis of allotment is finalized. The shares will be listed on NSE,BSE. After listing, you can trade the shares through your demat account.

What does the subscription rate mean for Nephrocare Health IPO IPO?

The subscription rate (also called subscription multiple) indicates how many times the IPO has been oversubscribed. For Nephrocare Health IPO IPO, the current subscription of 9.15 times means investors have bid for 9.15 times the number of shares offered. Since the subscription is above 1×, the IPO is fully subscribed. Higher subscription rates generally suggest strong market interest, but may also reduce individual allotment probability.

Should I invest in Nephrocare Health IPO IPO?

Investment decisions should be based on your own research, risk appetite, and financial goals. The Nephrocare Health IPO IPO has received 9.15 times subscription, showing moderate investor interest. Before investing, consider factors such as the company's business model, financial performance, industry outlook, price band valuation, and your investment objectives. It is recommended to consult with a financial advisor and read the Red Herring Prospectus (RHP) before making any investment decision. Past performance and subscription data are not indicative of future returns.

Understanding Nephrocare Health IPO Subscription Data

QIB Subscription

Qualified Institutional Buyers (QIBs) typically include foreign institutional investors (FIIs), domestic financial institutions, banks, insurance companies, and mutual funds. QIB subscription is often a key indicator of institutional investor confidence in the IPO. For Nephrocare Health IPO, the QIB category subscription stands at 16.01 times.

NII Subscription Breakdown

Non-Institutional Investors are high net-worth individuals and corporate entities investing above ₹2 lakh. The NII category is subdivided into bNII (bids above ₹10 lakh) and sNII (bids between ₹2 lakh and ₹10 lakh) to provide detailed insights into subscription patterns. For Nephrocare Health IPO, bNII subscription is 22.01 times, while sNII subscription is 9.58 times.

Retail Subscription

Retail Individual Investors can apply for shares up to ₹2 lakh in an IPO. Retail subscription is often the most closely watched metric as it reflects the interest of small investors. For Nephrocare Health IPO, retail subscription is 1.68 times. Higher retail subscription typically indicates strong retail investor interest and may impact allotment probability.

Investment Details

The Nephrocare Health IPO has a price band of ₹438 to ₹460 per share, with a lot size of 32 shares. Retail investors can apply with a minimum investment of ₹14,016 (at lower price) or ₹14,720 (at upper price).

Back to Nephrocare Health IPO Details